2001
DOI: 10.2169/internalmedicine.40.1077
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Renal Biopsy Samples of Patients with Diabetic Nephropathy.

Abstract: Objective To evaluate the usefulness of renal biopsy in the overall managementof patients with diabetes mellitus (DM), we examined the relationship between the clinical parameters and histopathological findings of renal biopsy samples.MethodsRenal biopsy specimens were obtained from 109 type 2 diabetic patients with proteinuria. Samples were divided into the following two groups: Diabetic Nephropathy (DN) group (n=80) had typical diabetic lesions without other renal diseases, complication group (n=29) had diab… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

9
40
2

Year Published

2005
2005
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 46 publications
(51 citation statements)
references
References 25 publications
9
40
2
Order By: Relevance
“…Different methods were used to assess DR: ophthalmoscopy after mydriasis in four studies [21,22,24,30,36]; fundus photography after mydriasis in one study [27]; ophthalmoscopy without mydriasis in four studies [15,23,26,28,29,33,34,40]; and in nine studies no relevant details were provided [8, 10, 25, 31-33, 35, 38, 39]. Of the nine prospective studies assessed, five were screening studies conducted on consecutive patients with type 2 diabetes mellitus and proteinuria [21][22][23][24][25], while the remaining four were conducted on selected type 2 diabetes mellitus populations using criteria for the biopsy for type 1 diabetes mellitus (microhaematuria, absence of DR, atypical change in renal function, or immunological abnormalities) [26][27][28][29]. However, in most DR predicting DN Forest plots of the pooled sensitivity and specificity are shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Different methods were used to assess DR: ophthalmoscopy after mydriasis in four studies [21,22,24,30,36]; fundus photography after mydriasis in one study [27]; ophthalmoscopy without mydriasis in four studies [15,23,26,28,29,33,34,40]; and in nine studies no relevant details were provided [8, 10, 25, 31-33, 35, 38, 39]. Of the nine prospective studies assessed, five were screening studies conducted on consecutive patients with type 2 diabetes mellitus and proteinuria [21][22][23][24][25], while the remaining four were conducted on selected type 2 diabetes mellitus populations using criteria for the biopsy for type 1 diabetes mellitus (microhaematuria, absence of DR, atypical change in renal function, or immunological abnormalities) [26][27][28][29]. However, in most DR predicting DN Forest plots of the pooled sensitivity and specificity are shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The diamond and vertical lines/brackets represent the pooled estimate with its 95% CI specificity, positive predictive value and negative value of PDR predicting biopsy-proven DN. Only four studies evaluated DR graded as simple or proliferative DR [8,21,24,28]. The sensitivity ranged from 0.03 to 0.57 (pooled sensitivity 0.25, 95% CI 0.16, 0.35), while the specificity ranged from 0.93 to 1.00 (pooled specificity 0.98, 95% CI 0.92, 1.00).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…[21][22][23] We have used a similar grading system modified to suit diffuse endocapillary proliferative glomerulonephritis. We have further tried to predict those cases with adverse outcome by combining the clinical and histological parameters which differed significantly between the groups with good and poor outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…Both type 1 and 2 diabetic nephropathies are characterized by the appearance of microalbuminuria, which leads to overt proteinuria and progressive loss of GFR (18). However, a series of renal biopsies in patients with type 2 diabetes and proteinuria revealed that a significant proportion of these patients had glomerular lesions other than the classic lesions associated with type 1 diabetic nephropathy (19,20). ACE-I, which improve glomerular permeability in patients with type 1 diabetes as assessed by dextran clearances, do not do so in patients with type 2 diabetes (21).…”
Section: Renin-angiotensin System Blockade For Renoprotectionmentioning
confidence: 99%